JOUNCE THERAPEUTICS INC's ticker is JNCE and the CUSIP is 481116101. A total of 100 filers reported holding JOUNCE THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 0.88 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $88,430 | -79.1% | 47,800 | -87.4% | 0.00% | -100.0% |
| Q4 2022 | $422,355 | -36.4% | 380,500 | +34.1% | 0.00% | -50.0% |
| Q3 2022 | $664,000 | -31.6% | 283,800 | -11.5% | 0.00% | -33.3% |
| Q2 2022 | $971,000 | -56.2% | 320,500 | -1.8% | 0.00% | -50.0% |
| Q1 2022 | $2,217,000 | -49.5% | 326,500 | -37.9% | 0.01% | -45.5% |
| Q4 2021 | $4,388,000 | +56.9% | 525,500 | +39.6% | 0.01% | +57.1% |
| Q3 2021 | $2,797,000 | +89.0% | 376,500 | +73.0% | 0.01% | +75.0% |
| Q2 2021 | $1,480,000 | +74.1% | 217,600 | +162.8% | 0.00% | +100.0% |
| Q1 2021 | $850,000 | +385.7% | 82,800 | +227.3% | 0.00% | +100.0% |
| Q2 2020 | $175,000 | -25.5% | 25,300 | -48.8% | 0.00% | 0.0% |
| Q1 2020 | $235,000 | -77.2% | 49,400 | -58.2% | 0.00% | -50.0% |
| Q4 2019 | $1,031,000 | +119.8% | 118,100 | -16.2% | 0.00% | +100.0% |
| Q3 2019 | $469,000 | -37.6% | 140,900 | -7.2% | 0.00% | -50.0% |
| Q2 2019 | $752,000 | -37.4% | 151,900 | -21.6% | 0.00% | -33.3% |
| Q1 2019 | $1,202,000 | +33.4% | 193,800 | -27.5% | 0.00% | +50.0% |
| Q4 2018 | $901,000 | -33.3% | 267,400 | +28.7% | 0.00% | -33.3% |
| Q3 2018 | $1,350,000 | +124.6% | 207,700 | +164.6% | 0.00% | +50.0% |
| Q2 2018 | $601,000 | – | 78,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP II, LLC | 1,347,829 | $4,084,000 | 88.46% |
| Ally Bridge Group (NY) LLC | 550,000 | $1,667,000 | 1.52% |
| TRV GP III, LLC | 1,148,780 | $3,481,000 | 1.42% |
| Deep Track Capital, LP | 4,259,653 | $12,907,000 | 0.85% |
| COWEN AND COMPANY, LLC | 2,843,149 | $8,615,000 | 0.83% |
| PFM Health Sciences, LP | 3,949,668 | $11,967,000 | 0.46% |
| RTW INVESTMENTS, LP | 4,358,433 | $13,206,000 | 0.34% |
| Omega Fund Management, LLC | 275,513 | $835,000 | 0.27% |
| Sofinnova Investments, Inc. | 981,928 | $2,975,000 | 0.25% |
| Orbimed Advisors | 2,928,900 | $8,875,000 | 0.16% |